In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...
Amgen (AMGN) closed at $366.44 in the latest trading session, marking a -2.06% move from the prior day. The stock's change ...
The Investment Committee give you their top stocks to watch for the second half.
Nearly 1 million bottles of the medication are being recalled because they may contain a foreign substance, according to an ...
By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...
Zacks Investment Research on MSN
Amgen (AMGN) upgraded to buy: What does it mean for the stock?
Investors might want to bet on Amgen (AMGN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most ...
Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...
If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...
By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...
Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...
Amgen (AMGN) stock is in focus as an expert panel of the European Medicines Agency recommends withdrawal of the company's ...
It would cut billions of dollars in Medicare outpatient drug payments to many hospitals participating in the 340B drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results